Conclusions
-
1.
Thirty acutely depressed patients were treated with imipramine and amitriptyline for periods of three weeks each in a double blind cross-over design. Twenty-four patients completed the six weeks study period. Clinical improvement on a highly significant level occurred for both drugs. No significant differences could be noted between drugs with the exception of a near significant difference existing at the ten day interval, amitriptyline producing more improvement than imipramine. However, this difference disappeared at the twenty day period. Amitriptyline appears to produce improvement somewhat faster than imipramine, but after about three weeks, imipramine has caught up with amitriptyline. Improvement with both drugs occurred within the first three weeks and could be maintained for another three weeks by the other agent, i.e., drugs were interchangeable after the first three week period.
-
2.
The clinical change noted by the physician may not correspond with the subjective change reported by the patient. The patient may feel improved even though this improvement may not be noticeable to the physician. Even if noticeable, the patient may attribute more importance to such an improvement than does the physician.
-
3.
A cross-over design appears to be inadequate in studies in which one may expect major change to occur within the initial study period. Furthermore, randomization of patients, according to a given criteria, does not necessarily provide randomization for other criteria (e.g., psychological test results in this study).
Similar content being viewed by others
References
Aivazian, G. H.: Amitriptyline in the treatment of depressive states. Dis. nerv. Syst.23, 410–415 (1962).
Ayd, F. J.: Amitriptyline (Elavil) therapy for depressive reactions. Psychosomatics1, 320–325 (1960).
Barsa, J. A., andJ. C. Saunders: Amitriptyline (Elavil), a new antidepressant. Amer. J. Psychiat.117, 739–740 (1961).
Freyhan, F. A.: Clinical effectiveness of Tofranil in the treatment of depressive psychoses. Canad. psychiat. Ass. J.4, S87-S99 (1959).
Hohn, R., G. Gross, M. Gross, andL. Lasagna: A double-blind comparison of placebo and imipramine in the treatment of depressed patients in a state hospital. J. psychiat. Res.1, 76–91 (1961).
Keup, W., A. Apolito, L. Olinger, M. Schwartz, andE. Yachnes: Inpatient treatment of depressive states with Tofranil (imipramine hydrochloride). Amer. J. Psychiat.116, 257–258 (1959).
Klein, D., andM. Fink: Psychiatric reaction patterns to imipramine. Amer. J. Psychiat.119, 432–438 (1962).
Kuhn, R.: The treatment of depressive states with G22355 (imipramine hydrochloride). Amer. J. Psychiat.115, 459–464 (1958).
Lemere, F.: Negative results in the treatment of depression with imipramine hydrochloride (Tofranil). Amer. J. Psychiat.116, 258–259 (1959).
Pressman, M., andL. Weiss: Experiences with Elavil: Treatment of fifty-one cases of depression. Amer. J. Psychiat.118, 74–75 (1961).
Rickels, K.: The controlled clinical trial in psychopharmacologic research. Psychosom. Med., The First Hahnemann Symposium (Nodine and Moyer, Eds.), pp. 421–426. Philadelphia: Lea & Febiger 1962.
—: Psychopharmacologic agents: A clinical psychiatrist's individualistic point of view: Patient and doctor variables. J. nerv. ment. Dis.136, 540–549 (1963).
—,T. Clark, J. Ewing, andW. Klingensmith: Evaluation of tranquilizing drugs in medical outpatients (A controlled study of amobarbital, meprobamate, prochlorperazine, and placebo). J. Amer. med. Ass.171, 1649–1656 (1959).
Rothman, T., H. Grayson, andJ. Ferguson: A comparative investigation of isocarboxazid and imipramine in depressive syndromes. J. Neuropsychiat.3, 234–240 (1962).
Wittenborn, J. R., M. Plante, F. Burgess, andH. Maurer: A comparison of imipramine, electroconvulsive therapy and placebo in the treatment of depressions. J. nerv. ment. Dis.135, 131–137 (1962).
Author information
Authors and Affiliations
Additional information
Instructor in Psychiatry.
This work was supported in part by USPHS Grant MY 2934 (Dr.Rickels, Principal Investigator) and in part by a grant-in-aid from Hoffmann-La Roche Inc. The study was carried out at the Psychiatric Unit of Mercy-Douglass Hospital, Philadelphia, Pa.
Rights and permissions
About this article
Cite this article
Snow, L.H., Rickels, K. The controlled evaluation of imipramine and amitriptyline in hospitalized depressed psychiatric patients. Psychopharmacologia 5, 409–416 (1964). https://doi.org/10.1007/BF02193477
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02193477